Imaging for the diagnosis and response assessment of renal tumours
Author:
Funder
The Urology Foundation
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/article/10.1007/s00345-018-2342-3/fulltext.html
Reference101 articles.
1. Znaor A, Laversanne M, Bray F (2017) Less overdiagnosis of kidney cancer? An age-period-cohort analysis of incidence trends in 16 populations worldwide. Int J Cancer 141(5):925–932. https://doi.org/10.1002/ijc.30799 . Accessed 1 Mar 2018
2. UK CR Kidney cancer incidence statistics. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/kidney-cancer/incidence . Accessed 1 Mar 2018
3. Rossi SH, Klatte T, Usher-Smith J, Stewart GD (2018) Epidemiology and screening for renal cancer. World J Urol. https://doi.org/10.1007/s00345-018-2286-7
4. Heilbrun ME, Yu J, Smith KJ, Dechet CB, Zagoria RJ, Roberts MS (2012) The cost-effectiveness of immediate treatment, percutaneous biopsy and active surveillance for the diagnosis of the small solid renal mass: evidence from a Markov model. J Urol 187(1):39–43. https://doi.org/10.1016/j.juro.2011.09.055
5. Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders P, Powles T, Staehler M, Volpe A, Bex A (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913–924. https://doi.org/10.1016/j.eururo.2015.01.005
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effective strategies to enhance the diagnosis and treatment of RCC: The application of biocompatible materials;Materials Today Bio;2024-08
2. Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT;Health Technology Assessment;2024-08
3. UCHL5 is a putative prognostic marker in renal cell carcinoma: a study of UCHL family;Molecular Biomedicine;2024-07-22
4. A CAIX Dual-Targeting Small-Molecule Probe for Noninvasive Imaging of ccRCC;Molecular Pharmaceutics;2024-06-04
5. Utility of PSMA PET/CT in Staging and Restaging of Renal Cell Carcinoma: A Systematic Review and Metaanalysis;Journal of Nuclear Medicine;2024-05-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3